This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!
Straight Talk About Treating Liver Tumors Webinar Announced
NewswireToday - /newswire/ -
Canton, TX, United States, 01/20/2008 - Dr. Charlie Nutting presents "Yttrium 90 Radioembolization (SIR-spheres or Therasphere) of Hepatic Malignancies".
Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.
Discovering that you or a loved one has liver involvement from cancer is frightening. The prognosis can be very scary and options can be few. As life seems to spin out of control, Yttrium 90 Microspheres Education and Support (y90support.org) offers support and hope to those affected by liver tumors so that no one faces their journey alone.
We are offering the following webinar to increase the awareness of Yttrium 90 Radioembolization. This procedure for advanced liver tumors utilizes millions of tiny radioactive beads to deliver targeted, internal radiation therapy to the tumor(s). Patients who are not candidates for liver resection or other targeted liver treatment choices will sometimes qualify for this novel treatment.
Date & Time:
01/31/08 2:00 pm (US/Eastern)
Duration: 60 minutes
Speaker Information:
Dr. Charlie Nutting is a fellowship trained, board certified interventional radiologist specializing in Interventional Oncology procedures. He was the first physician in the United States to perform hepatic radioembolization with SIR-Spheres in March, 2002. Since then he has performed over 300 radioembolizations utilizing both Therasphere and SIR-spheres products. He has been co-author on several important clinical papers regarding the use of radioactive microspheres.
"Taking advantage of the tumor's own increased blood supply is what is so elegant about the delivery of radioactive microspheres. We can target very high radiation doses into the tumors and sill relatively spare the normal liver tissue." His practice also includes chemoembolization as well as image guided radiofrequency ablation of liver, kidney, and lung tumors.
Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements
Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.
Your Banner Ad showing on ALL Health/Surgery articles, CATCH Visitors via Your Competitors Announcements! Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Y90 Microspheres Education and Support securities in any jurisdiction including any other companies listed or named in this release.
slindley[.]y90support.org 
